Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates an updated version of the associated document on the page.
    Difference
    0.0%
    Check dated 2026-06-09T01:25:40.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision tag v3.5.4 was added and the previous tag v3.5.3 was removed, indicating an update to the page's revision history rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-05-18T13:57:23.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now shows an updated ClinicalTrials.gov interface revision (from v3.5.2 to v3.5.3). This reflects a minor platform/version update rather than a change to the study record content.
    Difference
    0.0%
    Check dated 2026-04-27T07:38:23.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T03:15:56.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-22T08:31:35.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor version update and does not alter the study details or page content.
    Difference
    0.0%
    Check dated 2026-03-07T19:32:17.000Z thumbnail image

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.